Staging is performed with the use of the International Federation of Gynecology and Obstetrics (FIGO) system and the tumor–node–metastasis (TNM) system. Continue reading “Staging Systems for Endometrial Cancer”
Staging is performed with the use of the International Federation of Gynecology and Obstetrics (FIGO) system and the tumor–node–metastasis (TNM) system. Continue reading “Staging Systems for Endometrial Cancer”
The 2018 International Federation of Gynecology and Obstetrics (FIGO) uterine cervical cancer staging system introduces a new primary tumor size cutoff value of 2 cm (ie, stage IB1 vs IB2), used to evaluate patients for fertility-sparing radical trachelectomy and to estimate prognosis. Continue reading “FIGO Staging Classification for Cervical Cancer”
The Edmonton Obesity Staging System (EOSS) is a novel risk-stratification system that classifies obese individuals into 5 graded categories, based on their morbidity and health-risk profile. Continue reading “Edmonton Obesity Staging System (EOSS)”
Germ cell tumours of the testis are the commonest malignancy in men aged 20-40 years. Considerable therapeutic improvements in management—based on the cancer’s responsiveness to chemotherapy that contains platinum—mean that over 95% of these patients can now expect to be cured.
Continue reading “Staging and Risk Stratification of Germ-Cell Tumors”
Copyright by MedicalCriteria.com